APA (7th ed.) Citation

Pillai, J. A., Bena, J., Bekris, L., Kodur, N., Kasumov, T., Leverenz, J. B., & Kashyap, S. R. (2023). Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease. Alzheimer's Research & Therapy, 15(1), 1. https://doi.org/10.1186/s13195-023-01203-y

Chicago Style (17th ed.) Citation

Pillai, Jagan A., James Bena, Lynn Bekris, Nandan Kodur, Takhar Kasumov, James B. Leverenz, and Sangeeta R. Kashyap. "Metabolic Syndrome Biomarkers Relate to Rate of Cognitive Decline in MCI and Dementia Stages of Alzheimer's Disease." Alzheimer's Research & Therapy 15, no. 1 (2023): 1. https://doi.org/10.1186/s13195-023-01203-y.

MLA (9th ed.) Citation

Pillai, Jagan A., et al. "Metabolic Syndrome Biomarkers Relate to Rate of Cognitive Decline in MCI and Dementia Stages of Alzheimer's Disease." Alzheimer's Research & Therapy, vol. 15, no. 1, 2023, p. 1, https://doi.org/10.1186/s13195-023-01203-y.